Abstract CT171: Cadonilimab in combination with lenvatinib and stereotactic body radiotherapy in potentially resectable hepatocellular carcinoma (UniRTX): A single-arm, phase II clinical trial
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822132
